But, they work differently in your body
View our full catalog
Nell VP, et al
Your PlexusDx clinician uses genetic insights alongside baseline metabolic markers, weight-loss response, and tolerability data to adjust your dual-compound formulation's semaglutide-to-tirzepatide ratio over time
FIGURE 4 3.2 Network pharmacology and molecular docking 3.2.1 Acquisition and enrichment analysis of common targets between LC and myocarditis To further explore the mechanism of LC in treating myocarditis, we identified LC targets using SwissTargetPrediction, PharmMapper, and CTD databases, resulting in a total of 152 target genes after removing duplicates from the three sources
Statistical analysis was performed by t -test (unpaired or paired, as indicated), one-way analysis of variance (ANOVA), two-way ANOVA (time treatment or genotype treatment) with post hoc comparisons (where appropriate, as indicated in the figure legends)